CN Patent

CN101687798B — 制备用于调节激酶级联的组合物的过程及其使用方法

Assigned to Antes Spv Co ltd · Expires 2012-08-15 · 14y expired

What this patent protects

本发明涉及包括2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-V-苯甲基乙酰胺及其甲磺酸盐和二盐酸化物的组合物。更具体的说，本发明提供了一种有效的合成2-(5-＜4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-苯甲基乙酰胺及其甲磺酸盐和二盐酸化物的过程以及使用本发明所述的组合物调节激酶级联中一种或一种以上组分的方法。

USPTO Abstract

本发明涉及包括2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-V-苯甲基乙酰胺及其甲磺酸盐和二盐酸化物的组合物。更具体的说，本发明提供了一种有效的合成2-(5-＜4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-苯甲基乙酰胺及其甲磺酸盐和二盐酸化物的过程以及使用本发明所述的组合物调节激酶级联中一种或一种以上组分的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101687798B
Jurisdiction
CN
Classification
—
Expires
2012-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Antes Spv Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.